TCM
CYTO

Tekla Capital Management’s Altamira Therapeutics Ltd CYTO Stock Holding History

Tekla Capital Management’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10
Closed -$457K – 193
2017
Q4 		$457K Hold
10
– – 0.02% 153
2017
Q3 		$635K Hold
10
– – 0.02% 142
2017
Q2 		$554K Hold
10
– – 0.02% 137
2017
Q1 		$712K Hold
10
– – 0.03% 131
2016
Q4 		$829K Hold
10
– – 0.04% 132
2016
Q3 		$1.34M Hold
10
– – 0.05% 128
2016
Q2 		$3.5M Hold
10
– – 0.15% 109
2016
Q1 		$3.04M Sell
10
-6
-38% -$2.14M 0.13% 102
2015
Q4 		$6.2M Sell
16
-10
-38% -$2.88M 0.22% 82
2015
Q3 		$7.5M Hold
26
– – 0.28% 82
2015
Q2 		$10.4M Buy
+26
New +$10.8M 0.39% 60

Other funds holding CYTO

SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return